These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 21879928
21. Smoking cessation in a blue-collar population: results from an evidence-based pilot program. Ringen K, Anderson N, McAfee T, Zbikowski SM, Fales D. Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249 [Abstract] [Full Text] [Related]
22. How effective and cost-effective was the national mass media smoking cessation campaign 'Stoptober'? Brown J, Kotz D, Michie S, Stapleton J, Walmsley M, West R. Drug Alcohol Depend; 2014 Feb 01; 135():52-8. PubMed ID: 24322004 [Abstract] [Full Text] [Related]
23. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness. Solberg LI, Maciosek MV, Edwards NM, Khanchandani HS, Goodman MJ. Am J Prev Med; 2006 Jul 01; 31(1):62-71. PubMed ID: 16777544 [Abstract] [Full Text] [Related]
24. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia. Bertram MY, Lim SS, Wallace AL, Vos T. Tob Control; 2007 Aug 01; 16(4):255-60. PubMed ID: 17652241 [Abstract] [Full Text] [Related]
25. The return on investment of a Medicaid tobacco cessation program in Massachusetts. Richard P, West K, Ku L. PLoS One; 2012 Aug 01; 7(1):e29665. PubMed ID: 22238633 [Abstract] [Full Text] [Related]
26. Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective. Javitz HS, Swan GE, Zbikowski SM, Curry SJ, McAfee TA, Decker DL, Patterson R, Jack LM. Am J Manag Care; 2004 Mar 01; 10(3):217-26. PubMed ID: 15032259 [Abstract] [Full Text] [Related]
27. Cost-benefit analysis of funding smoking cessation before surgery. Jiménez-Ruiz CA, Martín V, Alsina-Restoy X, de Granda-Orive JI, de Higes-Martínez E, García-Rueda M, Genovés-Crespo M, López-García C, Lorza-Blasco JJ, Márquez FL, Ramos-Pinedo Á, Riesco-Miranda JA, Signes-Costa J, Solano-Reina S, Vaquero-Lozano P, Rejas J. Br J Surg; 2020 Jul 01; 107(8):978-994. PubMed ID: 32372474 [Abstract] [Full Text] [Related]
28. How cost-effective is 'No Smoking Day'? Kotz D, Stapleton JA, Owen L, West R. Tob Control; 2011 Jul 01; 20(4):302-4. PubMed ID: 20472574 [Abstract] [Full Text] [Related]
29. An evaluation of usage patterns, effectiveness and cost of the national smoking cessation quitline in Thailand. Meeyai A, Yunibhand J, Punkrajang P, Pitayarangsarit S. Tob Control; 2015 Sep 01; 24(5):481-8. PubMed ID: 24920575 [Abstract] [Full Text] [Related]
38. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Boyd KA, Briggs AH. Addiction; 2009 Feb 10; 104(2):317-25. PubMed ID: 19149829 [Abstract] [Full Text] [Related]
40. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework. Connolly MP, Baker CL, Kotsopoulos N. J Med Econ; 2018 Jun 10; 21(6):571-576. PubMed ID: 29376747 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]